Cargando…

For avid glucose tumors, the SUV peak is the most reliable parameter for [(18)F]FDG-PET/CT quantification, regardless of acquisition time

BACKGROUND: This study is an assessment of the impact of acquisition times on SUV with [(18)F]FDG-PET/CT on healthy livers (reference organ with stable uptake over time) and on tumors. METHODS: One hundred six [(18)F]FDG-PET/CT were acquired in list mode over a single-bed position (livers (n = 48) o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sher, Avigaëlle, Lacoeuille, Franck, Fosse, Pacôme, Vervueren, Laurent, Cahouet-Vannier, Aurélie, Dabli, Djamel, Bouchet, Francis, Couturier, Olivier
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2016
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4779086/ https://www.ncbi.nlm.nih.gov/pubmed/26944734 http://dx.doi.org/10.1186/s13550-016-0177-8

Ejemplares similares

[(18)F]FDG Positron Emission Tomography within Two Weeks of Starting Erlotinib Therapy Can Predict Response in Non-Small Cell Lung Cancer Patients
por: Hachemi, Mammar, et al.
Publicado: (2014)

Deep Learning Approach to Automatize TMTV Calculations Regardless of Segmentation Methodology for Major FDG-Avid Lymphomas
por: Revailler, Wendy, et al.
Publicado: (2022)

Prognostic Value of Metabolic, Volumetric and Textural Parameters of Baseline [(18)F]FDG PET/CT in Early Triple-Negative Breast Cancer
por: Bouron, Clément, et al.
Publicado: (2022)

SUV(fdg): A standard-uptake-value (SUV) body habitus normalizer specific to fluorodeoxyglucose (FDG) in humans
por: Beattie, Bradley J., et al.
Publicado: (2022)

FDG Dose Extravasations in PET/CT: Frequency and Impact on SUV Measurements
por: Osman, Medhat M., et al.
Publicado: (2011)

Correlation of (18)F-FDG/PET SUV(max), SUV(mean), MTV, and TLG with HIF-1α in Patients with Colorectal Cancer
por: Kaymak, Zümrüt Arda, et al.
Publicado: (2021)

FDG-PET staging and importance of lymph node SUV in head and neck cancer
por: Kubicek, Gregory J, et al.
Publicado: (2010)

Cardiac Magnetic Resonance for Evaluating Catheter Related FDG Avidity
por: Jeong, Daniel, et al.
Publicado: (2016)

FDG avid solitary pulmonary nodule mimicking lung cancer
por: Alduraibi, Alaa Khalid
Publicado: (2022)

Incidental FDG‐Avid Focuses in Palatine Tonsils on PET/CT
por: Reinholdt, Kasper Basse, et al.
Publicado: (2022)

(18)F- FDG PET/CT joint assessment of early therapeutic response in rheumatoid arthritis patients treated with rituximab
por: FOSSE, Pacôme, et al.
Publicado: (2018)

Assessment of Mediastinal Tumors Using SUV(max) and Volumetric Parameters on FDG-PET/CT
por: Morita, Takahiro, et al.
Publicado: (2017)

Utility of SUV(max) on (18) F-FDG PET in detecting cervical nodal metastases
por: Lim, Rebecca S. M., et al.
Publicado: (2016)

Interobserver variability of image-derived arterial blood SUV in whole-body FDG PET
por: Hofheinz, Frank, et al.
Publicado: (2019)

Reproducibility of [18F]FDG PET/CT liver SUV as reference or normalisation factor
por: Zwezerijnen, Gerben J. C., et al.
Publicado: (2022)

Intra-operative use of PET probe for localization of FDG avid lesions
por: Molina, M.A., et al.
Publicado: (2009)

Preoperative Nodal (18)F-FDG Avidity Rather than Primary Tumor Avidity Determines the Prognosis of Patients with Advanced Gastric Cancer
por: Kwon, Hyun Woo, et al.
Publicado: (2018)

FDG-Avid Portal Vein Tumor Thrombosis from Hepatocellular Carcinoma in Contrast-Enhanced FDG PET/CT
por: Nguyen, Xuan Canh, et al.
Publicado: (2015)

Clinicopathologic parameters associated with the FDG-avidity in staging of early gastric cancer using (18)F-FDG PET
por: Yoon, Joon-Kee, et al.
Publicado: (2019)

Distribution of FDG-avid nodes in esophageal cancer: implications for radiotherapy target delineation
por: Garcia, Brandon, et al.
Publicado: (2016)

Response of FDG avid pelvic bone marrow to concurrent chemoradiation for anal cancer
por: Robinson, Maxwell, et al.
Publicado: (2020)

Malignancy Risk in (18)F-FDG-Avid Thyroid Incidentalomas: Controversies and Limitations
por: Bukhari, Khulood, et al.
Publicado: (2021)

Multiple Subcutaneous (18)F-FDG-avid Granulomas Due to Enoxaparin Injection
por: Erol Fenercioğlu, Özge, et al.
Publicado: (2022)

Increased FluoroDeoxyGlucose (FDG) Avidity Following COVID-19 Vaccination
por: Nassar, Mo’ath, et al.
Publicado: (2022)

Relation between nodule size and (18)F-FDG-PET SUV for malignant and benign pulmonary nodules.
por: Khalaf, Majid, et al.
Publicado: (2008)

The effect of SUV discretization in quantitative FDG-PET Radiomics: the need for standardized methodology in tumor texture analysis
por: Leijenaar, Ralph T.H., et al.
Publicado: (2015)

Monitoring scanner calibration using the image-derived arterial blood SUV in whole-body FDG-PET
por: Maus, Jens, et al.
Publicado: (2018)

Prognostic Prediction of BRCA Mutations by (18)F-FDG PET/CT SUV(max) in Breast Cancer
por: Özdemir, Semra, et al.
Publicado: (2021)

When SUV Matters: FDG PET/CT at Baseline Correlates with Survival in Soft Tissue and Ewing Sarcoma
por: Hack, Ruben I., et al.
Publicado: (2021)

Potential Pitfall in the Assessment of Lung Cancer with FDG-PET/CT: Talc Pleurodesis Causes Intrathoracic Nodal FDG Avidity
por: Wang, Yingbing, et al.
Publicado: (2013)

Is it safe to drive SUVs?
Publicado: (1998)

Estimate of the impact of FDG-avidity on the dose required for head and neck radiotherapy local control
por: Jeong, Jeho, et al.
Publicado: (2014)

Increased FDG avidity in lymphoid tissue associated with response to combined immune checkpoint blockade
por: Tsai, Katy K., et al.
Publicado: (2016)

Anti-DPPX encephalitis: prominent nystagmus reflected by extraocular muscle FDG-PET avidity
por: Doherty, Leana, et al.
Publicado: (2017)

(18)F-FDG–Avid Axillary Lymph Nodes After COVID-19 Vaccination
por: Johnson, B. Jake, et al.
Publicado: (2021)

(18)FDG‐avid cholesterol granuloma mimicking residual aggressive lymphoma after chemotherapy
por: Falchi, Lorenzo, et al.
Publicado: (2021)

A Retrospective Study of predicting risk of Metastasis among FDG-avid Bone Lesions in (18)F-FDG PET/CT
por: Yao, Guangyu, et al.
Publicado: (2020)

FDG avid pulmonary amyloid nodule in a patient with metastatic renal cell cancer on 18F-FDG PET/CT
por: Lee, Marco Enoch, et al.
Publicado: (2021)

Calculating an estimate of tissue integrated activity in (18)F-FDG PET imaging using one SUV value
por: Laffon, Eric, et al.
Publicado: (2013)

The correlation of expression of VEGF and EGFR with SUV of (18)FDG-PET-CT in non-small cell lung cancer
por: Liu, Xiguang, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_s5froc57afpld2dlbtpmu67fh2